Skip to main content

Table 2 Prevalence of MetS and its individual components in both groups

From: Impact of insulin resistance and metabolic syndrome on disability in patients with multiple sclerosis

Metabolic syndrome components

Patient group

(n = 50)

N (%)

Control group

(n = 25)

N (%)

p value

Fasting glucose ≥100 mg/dL

15 (30%)

0 (0%)

0.001*

Blood pressure ≥ 130/85 mmHg

15 (30%)

2 (8%)

0.03*

Triglycerides ≥150 mg/dL

7 (14%)

0 (0%)

0.08

HDL-C < 40 mg/dL in men or < 50 mg/dL in women

17 (34%)

4 (16%)

0.2

Waist circumference ≥ 102 cm in men or ≥ 88 cm in women

19 (38%)

0 (0%)

< 0.001*

Metabolic syndrome

 No

39 (78%)

23 (92%)

0.04

 Yes

11 (22%)

2 (8%)

  1. HDL-C High-density lipoprotein cholesterol
  2. *p value < 0.05 is considered statistically significant